RxDoctor Payments Data

Wenfei Xie, MD

Dermatology · Kansas City, MONPI 1255643490

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.5% of the total across 567 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by AbbVie at 28.6% of the total.

$11,350in general payments, 2019–2025

Across 567 payments — averaging $20.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novartis$1K
  • Johnson & Johnson$1K
  • Lilly USA, LLC$1K
  • Sun Pharmaceutical Industries Inc.$666
  • Amgen$443
  • plus $4K from 27 others

What the payments were for

  • Food & beverage$11,06097%
  • Education$2893%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,350 in reported general payments places this provider in the 80th percentile of 263 dermatology providers in Missouri.

See all dermatology providers in Missouri

Medicare billing

Part B allowed, 2024
$314,045
Medicare patients
947
Services billed
5,896

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate157$9,502
Metronidazole58$3,265
Acitretin12$1,993
Ketoconazole131$1,839
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc75$1,288
Triamcinolone Acetonide116$725
Dapsone13$628
Fluocinonide14$575
Doxycycline Monohydrate46$457
ValacyclovirValacyclovir Hcl24$385
Mupirocin49$371
Clindamycin Phosphate18$371
Clotrimazole22$363
Minoxidil25$194
Finasteride23$155

Paid to pharmacies, not to this prescriber.

Other dermatology in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →